Potential role of cysteine and methionine in the protection against hormonal imbalance and mutagenicity induced by furazolidone in female rats

Toxicology

Volumn 243, Issue 1-2, 2008, Pages 31-42

  Ahmed, Hanaa H ^a   El Aziem, Sekena H Abd ^a   Abdel Wahhab, Mosaad A ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Furazolidone; Genotoxicity; Hormones; l Cysteine; l Methionine; Nitrofurans

Indexed keywords

CYSTEINE; FURAZOLIDONE; METHIONINE;

ADRENAL DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; ENDOCRINE DISEASE; FEMALE; GENOTOXICITY; MICRONUCLEUS TEST; MUTAGENICITY; NONHUMAN; OVARY DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTECTION; RANDOM AMPLIFIED POLYMORPHIC DNA; RAT; SPRAGUE DAWLEY RAT; THYROID DISEASE; VETERINARY MEDICINE;

ANIMALS; ANTIMUTAGENIC AGENTS; BASE PAIRING; CYSTEINE; DNA; ERYTHROCYTES; FEMALE; FOOD CONTAMINATION; FURAZOLIDONE; HORMONES; METHIONINE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MUTAGENS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RATS; RATS, SPRAGUE-DAWLEY; VETERINARY DRUGS;

ANIMALIA; RATTUS;

EID: 37149049934     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.09.018     Document Type: Article

References (99)

1. Abdel-Wahhab M.A., and Aly S.E. Antioxidants and radical scavenging properties of vegetable extracts in rats fed aflatoxin-contaminated diet. J. Agric. Food Chem. 51 (2003) 2409-2414
2. Abdel-Wahhab M.A., and Aly S.E. Antioxidant property of Nagilia Sativa (Black cumin) and Syzygium Aromaticum (Clove) in rats during Aflatoxicosis. J. Appl. Toxicol. 25 (2005) 218-223
3. 1. Pharm. Biol. 43 (2005) 515-525
4. Adam A., Marzuki A., Ngah W.Z., and Top G.M. Nitrofurantoin-induced hepatic and pulmonary biochemical changes in mice fed different vitamin E doses. Pharmacol. Toxicol. 79 (1996) 334-339
5. Ahmed H.H., and Abdel-Wahhab M.A. Protection against cadmium-induced toxicity in the rats: potential for hidden risks. J. Egypt. Soc. Toxicol. 22 (2000) 51-57
6. Ali B.H. Some pharmacological and toxicological properties of furazolidone. Vet. Res. Commun. 6 (1983) 1-11
7. Ali B.H. The effect of furazolidone on the adrenal glands of the chicken. Vet. Q. 5 (1983) 190-192
8. Ali B.H. Effect of furazolidone on tissue sulfhydryl groups, ascorbic acid and lipid peroxide levels in the rat and the influence of dimethyl sulphoxide thereon. Pharmacol. Res. 25 (1992) 247-254
9. Ali B.H., Silsby J., and el Halawani M.E. Effect of furazolidone and nitrofurazone on egg production, on plasma luteinising hormone and on prolactin concentrations in turkeys. Br. Poult. Sci. 28 (1987) 613-621
10. Ali B.H., Sisby J.L., Edens F., and el Halawani M.E. Effects of furazolidone or nitrofurazone on the concentrations of hypothalamic amines and plasma luteinizing hormone (LH) and prolactin (PRL), levels in young turkeys. Gen. Pharmacol. 19 (1988) 91-95
11. Ashby J., DeSerres F.J., Shelby M.D., Margolin B.H., Ishidate M.J.R., and Becking G.C. Evaluation of Short-term Tests for Carcinogens: Report of the International Programme on Chemical Safety's Collaborative Study on In Vivo Assays (1988), Cambridge University Press, Cambrige
12. Auro A., Sumano H., Ocampo L., and Barragan A. Evaluation of the carcinogenic effects of furazolidone and its metabolites in two fish species. Pharmacogenomics J. 4 (2004) 24-28
13. Babilé R., Queinnec G., Berland H.M., and Darré R. Chromosomal structure or porcine lymphocytes effected by food additives. CR Seances Soc. Biol. Fil. 172 (1987) 546-553
14. Balsam A., Sexton F., Borges M., and Ingbar S.H. Formation of diiodotyrosine from thyroxine-ether-link cleavage, an alternate pathway of thyroxine metabolism. J. Clin. Invest. 72 (1983) 1234-1245
15. Bartlet A.L., Harvey S., and Klandorf H. Contrasting effects of nitrofurans on plasma corticosterone in chickens following administration as a bolus or diet additive. J. Vet. Pharmacol. Ther. 13 (1990) 261-269
16. Bayer M.F., Kriss J.P., and McDougall I.R. Clinical experience with sensitive thyroprotein measurements: diagnostic and therapeutic implication. J. Nucl. Med. 26 (1985) 1248-1256
17. Becerril C., Ferrero M., Sanz F., and Castaño A. Detection of mitomycin C-induced genetic damage in fish cells by use of RAPD. Mutagénesis 14 (1999) 449-456
18. Blake-Tyrrell J., and Forsham P.H. Glucocorticoids and adrenal androgens. In: Greenspan F.S., and Forsham P.H. (Eds). Basic and Clinical Endocrinology (1985), Lang Medical, California 272-309
19. Boebel K.P., and Backer D.H. Blood and liver concentrations of glutathione and plasma concentrations of sulfur containing amino acids in chicks fed deficient, adequate, or excess levels of dietary cysteine. Proc. Soc. Exp. Biol. Med. 172 (1983) 498
20. CD., 1996. Commission Directive No. 96/23/EC, Off. J. Eur. Comm. No. L125/10.
21. CD., 2002. Commission Decision No. 2002/657/EC, Off. J. Eur. Comm. No. L221/8.
22. CD., 2003. Commission Decision No. 2003/181/EC of 13 March 2003, Off. J. Eur. Comm. No. L71/17.
23. Chen C.F., Hsueh C.W., Tang T.S., Wang D., Shen C.Y., and Pei J.S. Reperfusion liver injury-induced superoxide dismutase and catalase expressions and the protective effects of N-acetyl cysteine. Transplant. Proc. 39 (2007) 858-860
24. Czarnecki C.M. Influence of exogenous T4 on body weight, feed consumption, T4 levels, and myocardial glycogen in furazolidone-fed turkey poults. Avian Dis. 35 (1991) 930-936
25. De Angelis I., Hoogenboom L.A.P., Huveneers-oorsprong M.B.M., Zucco F., and Stammat A. Established cell lines for safety assessment of food contaminants: differing furazolidone toxicity to V79, HEp-2 and Caco-2 cells. Fd Chera. Toxic. 32 (1994) 481-488
26. De Angelis I., Vincentini O., Brambilla G., Stammati A., and Zucco F. Characterization of furazolidone apical-related effects to human polarized intestinal cells. Toxicol. Appl. Pharmacol. 152 (1998) 119-127
27. De Angelis I., Rossi L., Pedersen J.Z., Vignoli A.L., Vincentini O., Hoogenboom L.A., Polman T., Stammati H., and Zucco A.F. Metabolism of furazolidone: alternative pathways and modes of toxicity in different cell lines. Xenobiotica 29 (1999) 1157-1169
28. Dorval J., and Hontela A. Role of glutathione redox cycle and catalase in defense against oxidative stress induced by endosulfan in adrenocortical cells of rainbow trout (Oncorhynchus mykiss). Toxicol. Appl. Pharmacol. 192 (2003) 191-200
29. Endo A., Kinugawa T., Ogino K., Kato M., Hamada T., Osaki S., Igawa O., and Hisatoma I. Cardiac and plasma catecholamine responses to exercise in patients with type 2 diabetes: prognostic implications for cardiac-cerebrovascular events. Am. J. Med. Sci. 320 (2000) 24-30
30. EUCR., 1990. EU Council Regulation No. 2377/90/EC, Off. J. Eur. Comm. No. L224/1.
31. EUCR., 1993. EU Council Regulation No. 2901/93/EC, Off. J. Eur. Comm. No. L264/1.
32. EUCR., 1995. EU Council Regulation No. 1442/95/EC, Off. J. Eur. Comm. No. L143/26.
33. Farber T.M. Problems in the safety evaluation of tissue residues. J. Environ. Pathol. Toxicol. 3 (1980) 73-79
34. Finzi J.K., Donato J.L., Sucupira M., and De Nucci G. Determination of nitrofuran metabolites in poultry muscle and eggs by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 224 (2005) 30-35
35. Food and Drug Administration, 1976. Part V. New Animal Drugs. FUZ (NF-180), Fed. Register 41, 19906.
36. Fotouhi L., Kohestanian E., and Heravi M.M. The effect of metal ions on the electrochemistry of the furazolidone. Electrochem. Commun. 8 (2006) 565-570
37. Fucić A., Marković D., Ferencić Z., Mildner B., Jazbec A.M., and Spoljar J.B. Comparison of genomic damage caused by 5-nitrofurantoin in young and adult mice using the in vivo micronucleus assay. Environ. Mol. Mutagen. 46 (2005) 59-63
38. Gao N., Ni Y.C., Thornton-Manning J.R., Fu P.P., and Heflich R.H. Mutagenicity of nitrofurantoin and furazolidone in Chinese hamster ovary cell strains. Mutat. Res. 225 (1989) 181-187
39. Gottschall D.W., and Wang R. Depletion and bioavailability of 14C-oxibendazole residues in swine tissues. Vet. Parasitol. 64 (1995) 83-93
40. Granner D.K. Pituitary and hypothalamic hormones. In: Murray R.K., Granner D.K., Mayes P.A., and Rodwell V.W. (Eds). Harper's Biochemistry. 25th ed. (middle East Edition) (1999), Appelton & Lange, Norwalk, Connecticut/ San Mateo, California 550-560
41. Hassan N.S., Weshahy K.M., Ahmed H.H., and Abdel-Wahhab M.A. Effects of antioxidants on oxidative stress of pyriproxyfen in female rats. Med. J. Cairo Univ. 69 (2001) 83-94
42. Huber W.G., Becket S.R., and Archer B.P. Bioavailability of residues: current status. J. Environ. Pathol. Toxicol. 3 (1980) 45-63
43. Huber R., Streng S., and Bauchinger M. The suitability of the human lymphocyte micronucleus assay system for biological dosimetry. Mutat. Res. 111 (1983) 185-193
44. Jager L.P., de Graaf G.J., and Widjaja-Greefkes H.C. Differential effects of nitrofurans on the production/release of steroid hormones by porcine adrenocortical cells in vitro. Eur. J. Pharmacol. 331 (1997) 325-331
45. Jankus E.F., Noren G.R., and Staley N.A. Furazolidone induced cardiac dilatation in turkeys. Avian Dis. 16 (1972) 958-961
46. Kauffman A.S. Emerging functions of gonadotropin-releasing hormone II in mammalian physiology and behaviour. J. Neuroendocrinol. 16 (2004) 794-806
47. Khan L.A., Jalali S., Andrabi S.M., and Mirza M.A. Serum profiles of luteinizing hormone, oestradiol and cholesterol and ovarian functions in layer poultry birds (Gallus domesticus) fed diets containing furazolidone. Vet. Res. Commun. 28 (2004) 247-259
48. Kleinman W.A., and Richie Jr. J.P. Status of gluthathione and other thiols and disulfates in human plasma. Biochem. Pharmacol. 60 (2000) 19-29
49. Laurentius A.P., Hoogenboom L.A.P., Gerard D., van Bruchem G.D., Kim Sonne K., Enninga I.C., van Rhijn J.A., Heskamp H., Huveneers-Oorsprong M.B.M., van der Hoeven J.C.M., and Kuiper H.A. Absorption of a mutagenic metabolite released from protein-bound residues of furazolidone. Environ. Toxicol. Pharmacol. 11 (2002) 273-287
50. Law F.C.P., and Meng J. Binding of 14C-furazolidone metabolites to the muscular and hepatic proteins of trout. Food Addit. Contam. 13 (1996) 199-209
51. Lax D., and Kukolich S.G. Generation of furazolidone radical anion and its inhibition by glutathione. Biochem. Med. Metab. Biol. 48 (1992) 56-63
52. Leopold F. Glutathione peroxidase brought into focus. In: Pryor W.A. (Ed). In Free Radicals in Biology vol. V (1976), Academic Press, Inc., New York 223-254
53. Levine R.L., Berlett B.S., Moskovitz J., Mosoni L., and Stadtman E.R. Methionine residues may protect proteins from critical oxidative damage. Mech. Ageing Dev. 107 (1999) 323-332
54. McCalla D.R. Mutagenicity of nitrofuran derivatives: review. Environ. Mutagen. 5 (1983) 745-765
55. McCracken R.J., and Kennedy D.G. Detection, accumulation and distribution of nitrofuran residues in egg yolk, albumen and shell. Food Addit. Contam. 24 (2007) 26-33
56. McCracken R.J., Van Rhijn J.A., and Kennedy D.G. The occurrence of nitrofuran metabolites in the tissues of chickens exposed to very low dietary concentrations of the nitrofurans. Food addit. Contam. 22 (2005) 567-572
57. Meister A. Selective modification of glutathione metabolism. Science 220 (1983) 472-477
58. Mena F., Clapp C., Aguayo D., Lorenson M.Y., and Martinez-Escalera G. Thiol regulation of depletion-transformation and release of prolactin by the pituitary of the lactating rat. Endocrinology 118 (1986) 1795-1802
59. Moema A.H., Cesar J., Freitas Jr. M., and Monteiro-Leal L.H. The effects of metronidazole and furazolidone during Giardia differentiation into cysts. Exp. Parasitol. 113 (2006) 135-141
60. Ozawa Y., Shimizu T., and Shishiba Y. Effects of sulfhydryl reagents on the conversion of thyroxine to 3,5,3-triiodothyronine: direct action on thyroxine molecules. Endocrinology 110 (1982) 241-245
61. Parker F. Skin and hormones. In: Williams R.H. (Ed). Textbook of Endocrinology (1981), W.B. Saunders Co., Philadelphia 1080-1098
62. Pasha K.V., and Vijayan E. Glutathione distribution in rat brain at different ages and the effect of intraventricular glutathione on gonadotropin levels in ovariectomized steroid-primed rats. Brain Res. Bull. 22 (1989) 617-619
63. Patra R.C., Swarup D., and Dwivedi S.K. Antioxidant effects of alpha tocopherol, ascorbic acid and l-methionine on lead induced oxidative stress to the liver, kidney and brain in rats. Toxicology 162 (2001) 81-88
64. Plotsky Y., Kaiser M.G., and Lamont S.J. Genetic characterization of highly inbred chicken lines by two DNA methods: DNA fingerprinting and polymerase chain reaction using arbitrary primers. Anim. Genet. 26 (1995) 163-170
65. Poirier M.B., Laflamme L., and Langlois M.F. Identification and characterization of RanBPM, a novel coactivator of thyroid hormone receptors. J. Mol. Endocrinol. 36 (2006) 313-325
66. Raipulis J., Toma M.M., and Semjonovs T.P. The effect of probiotics on the genotoxicity of furazolidone. Int. J. Food Microbiol. 102 (2005) 343-347
67. Ramanathan K., Balakumar B.S., and Panneerselvam C. Effects of ascorbic acid and alpha tocopherol on arsenic induced oxidative stress. Hum. Exp. Toxicol. 21 (2002) 675-680
68. Ratcliffie W.A., Carter G.D., Dowsett M., Hillier S.G., Middle J.G., and Reed M.J. Estradiol assays: applications and guidelines for the provision of clinical biochemistry service. Ann. Clin. Biochem. 25 (1988) 466-483
69. Robbins J. Thyroxin-binding protein in serum. In: Sunderman F.W., and Sunderman Jr. F.W. (Eds). Laboratory Diagnosis of Endocrine Diseases (1971), Warren H. Green Inc., St. Louis, MO 211
70. Santa-Coloma T.A., Grasso P., and Reichert L.E. Sulfhydryl groups are involved in the interaction of FSH with its receptor. Biochem. Biophys. Res. Commun. 176 (1991) 1256-1261
71. SAS. SAS User's Guide: Statistics (1982), SAS Institute, Cary, NC
72. Sato T., Maruyama S., and Nomura K. On the role of NADPH and glutathione in the catalytic mechanism of hepatic thyroxine 5-deiodination. Endocrinol. Jpn. 28 (1981) 451-459
73. Schnild W. The micronucleus test. Mutat. Res. 31 (1975) 9-15
74. Sen C.K. Glutathione homeostasis in response to exertraining and nutritional supplements. Mol. Cell. Biochem. 196 (1999) 31-42
75. Sesh P.S., Singh D., Sharma M.K., and Pandey R.S. Activity of glutathione related enzymes and ovarian steroid hormones in different sizes of follicles from goat and sheep ovary of different reproductive stages. Indian J. Exp. Biol. 39 (2001) 1156-1159
76. Sharma D., Appa Rao K.B.C., and Totey S.M. Measurement of within and between population genetic variability in quails. Br. Poult. Sci. 41 (2000) 29-32
77. Skrzydlewska E., and Farbiszewski R. Protective effect of N-acetylcysteine on reduced glutathione, reduced glutathione-related enzymes and lipid peroxidation in methanol intoxication. Drug Alcohol Depend. 57 (1999) 61-67
78. Slapsyte G., Jankauskiene A., Mierauskiene J., and Lazutka J.R. Cytogenetic analysis of children under long-term antibacterial therapy with nitroheterocyclic compound furagin. Mutat. Res. 491 (2001) 25-30
79. Slapsyte G., Jankauskiene A., Mierauskiene J., and Lazutka J.R. Cytogenetic analysis of peripheral blood lymphocytes of children treated with nitrofurantoin for recurrent urinary tract infection. Mutagenesis 17 (2002) 31-35
80. Staley N.A., Noren G.R., Bandt C.M., and Sharp H.L. Furazolidone induced cardiomyopathy in turkeys. Association with a relative alpha-l antitrypsin deficiency. Am. J. Pathol. 9 (1978) 531-544
81. Stroo W.E., and Schaffer S.W. Furazolidone-enhanced production of the free radicals by avian cardiac and microsomal membranes. Toxicol. Appl. Pharmncol. 98 (1989) 81-86
82. Takahashi M., Iizuka S., Watanabe T., Yoshida M., Ando J., Wakabayashi K., and Maekawa A. Possible mechanisms underlying mammary carcinogenesis in female Wistar rats by nitrofurazone. Cancer Lett. 156 (2000) 177-184
83. Takegawa K., Mitsumori K., Yasuhara K., Moriyasu M., Sakamori M., Onodera H., Hirose M., and Nomura T. A mechanistic study of ovarian carcinogenesis induced by nitrofurazone using ras H2 mice. Toxicol. Pathol. 28 (2000) 649-655
84. Tietz N.W. Fundamental of Clinical Chemistry (1987), Saunders Press, Philadelphia p. 588
85. Titenko-Holland N., Windham G., Kolachana P., Reinisch F., Parvatham S., Osorio A.M., and Smith M.T. Genotoxicity of malathion in human lymphocytes assessed using the micronucleus assay in vitro and in vivo: a study of malathion exposed workers. Mutat. Res. 338 (1997) 85-95
86. van Koten-Vermeulen, J.E.M., Wouters, M.F.A., van Leeuwen, F.X.R., 1993. Report of the 40th Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), World Health Organization, Geneva, WHOTRS no. 832, pp. 32-40, http://www.who.int/ipcs/publications/jecfa/ reports/en/index.html.
87. Van Vleet J.F., and Ferrans V.J. Furazolidone-induced congestive cardiomyopathy in ducklings: lack of protection from selenium, vitamin E and taurine supplements. Am. J. Vet. Res. 44 (1983) 143-1148
88. Vara E., Arias D.J., Villa N., Hernandez J., Garica C., Orti P., and Balibrea J.L. Beneficial effect of S-adenosylmethionine during both cold storage and cryopreservation of isolated hepatocytes. Cryobiology 32 (1995) 422-427
89. Verdon E., Couedor P., and Sanders P. Multi-residue monitoring for the simultaneous determination of five nitrofurans (furazolidone, furaltadone, nitrofurazone, nitrofurantoine, nifursol) in poultry muscle tissue through the detection of their five major metabolites (AOZ, AMOZ, SEM, AHD, DNSAH) by liquid chromatography coupled to electrospray tandem mass spectrometry: in-house validation in line with Commission Decision 657/2002/EC. Anal. Chim. Acta 586 (2007) 336-347
90. Vincentini O., De Angelis I., Stammati A., and Zucco F. Functional alterations induced by the food contaminant furazolidone on the human tumoral intestinal cell line Caco-2. Toxicol. In Vitro 7 (1993) 403-406
91. Vroomen L.H., Berghmans M.C.J., van Leeuwen P., van der Struijs T.D.B., de Vries P.H.U., and Kuiper H.A. Kinetics of 14C-furazolidone in piglets upon oral administration during 10 days and its interaction with tissue macro-molecules. Food Addit. Contam. 3 (1986) 331-336
92. Vroomen L.H., Groten J.P., van Muiswinkel K., van Velduizen A., and van Bladeren P.J. Identification of a reactive intermediate of furazolidone formed by swine liver microsomes. Chem. Biol. Interact. 64 (1987) 167-179
93. Vroomen L.H., Berghmans M.C.J., Groten J.P., Koeman J.H., and van Bladeren P.J. Reversible interaction of a reactive intermediate derived from furazolidone with glutathione and protein. Toxicol. Appl. Pharmacol. 95 (1988) 53-60
94. Vroomen L.H., Berghmans M.C.J., van Bladeren P.J., Groten J.P., Wissink C.J., and Kuiper H.A. In vivo and in vitro metabolic studies of furazolidone: a risk evaluation. Drug Metab. Rev. 22 (1990) 663-667
95. Waller R.A., and Duncan D.B. A Bayes rule for the symmetric multiple comparison problems. J. Am. Stat. Assoc. 64 (1969) 1484-1503
96. Weitberg A.B., Weitzman S.A., Clark E.P., and Stossel T.P. Effects of antioxidants on antioxidant-induced sister chromatid exchange formation. J. Clin. Invest. 75 (1985) 1835-1841
97. Williams J.K.G., Kubelik A.R., Livak K.J., Rafalsky J.A., and Tyngey S.V. DNA polymorphisms amplified by arbitary primers are useful as genetic markers. Nucleic Acids Res. 18 (1990) 6531-6535
98. Wisdom G.P. Enzyme-immunoassay. Clin. Chem. 22 (1976) 1243-1255
99. Zolla L., and Timperio A.M. Involvement of active oxygen species in protein and oligonucleotide degradation induced by nitrofurans. Biochem. Cell. Biol. 83 (2005) 166-175